Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy - Biognosys

Quantitative Proteomics Reveals Novel Immunomodulatory Pathways of Resistance to PARP Therapy

Posters

E-Poster presented at AACR 2020

Presenter: Kristina Beeler, PhD
A collaboration with: Cancer Research UK Cambridge Institute

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More